[Clinical trial of Pilogel HS made by Alcon].
The authors give an account on the results of clinical tests of the anti-glaucomatous preparation PILOGEL HS of ALCON Co. The drug replaced in all groups of patients reliably 1-3% Pilocarpine administered three times a day, as regards its effect on intraocular tension. Its great practical advantage is that the effect is achieved after a single administration per 24 hours (at night). In particular patients in their productive age appreciate this advantage. The preparation was included in the import plan.
Vymazal
M
M
Katedra chorob ocních LF UP, Olomouc.
Válková
Z
Z
Poláchová
M
M
Dokonalová
E
E
Dragounová
H
H
Jezdinský
J
J
D000368:Aged; D002986:Clinical Trials as Topic; D005260:Female; D005782:Gels; D005902:Glaucoma, Open-Angle / Q000188:drug therapy*; D006801:Humans; D008297:Male; D008875:Middle Aged; D010862:Pilocarpine / Q000008:administration & dosage* / Q000009:adverse effects / Q000627:therapeutic use; D013999:Timolol / Q000008:administration & dosage / Q000627:therapeutic use
D005782:Gels; D010862:Pilocarpine; D013999:Timolol
Klinické zkousení prípravku Pilogel HS firmy Alcon.